KIT and ovarian serous carcinoma: The abundance of CD117 on EVs isolated from urine of patients with highly invasive serous ovarian carcinoma is not surprising since these tumors are known to be highly invasive with a documented mesenchymal signature, particularly with high CD117 expression (Foster et al., 2018).